Resumen
Introducción: La COVID-19, retó a nuestro sistema de salud, dentro del amplio espectro clínico la lesión renal aguda se presentó como un evento catastrófico, la lesión renal aguda y el riesgo de dependencia posterior a diálisis constituye un problema clínico con alta repercusión en la funcionalidad.
Objetivo: identificar los factores de riesgo para la dependencia a diálisis posterior a lesión renal aguda por COVID-19.
Material y métodos: se realizó un estudio de cohorte observacional retrospectivo en el Hospital de Especialidades del Centro Médico Nacional Siglo XXI, del Instituto Mexicano del Seguro Social, del periodo de marzo del 2020 a marzo del 2021. Se incluyeron 317 pacientes, realizamos estadística descriptiva, comparamos diferencias entre los estadios de lesión renal aguda encontrando diferencia en obesidad con frecuencia de 2.2% en estadio 1, de 20.82% estadio 2 y de 14.51% estadio 3, con valor p = 0.018.
Resultados: encontramos la dependencia a diálisis a un año posterior a lesión renal aguda intrahospitalaria inducida por COVID-19 en 58 pacientes (18.9%), analizamos por estadio de KDIGO, en aquellos pacientes que cursaron con LRA KDIGO 1 (2.83%) dependió de diálisis a un año, en el estadio KDIGO 2 (3.78%), en el estadio KDIGO 3 (11.67%)
Conclusiones: nuestro estudio permitió identificar que los factores de riesgo que se asocian con dependencia a diálisis son: sexo masculino, diabetes mellitus tipo 2, obesidad, enfermedad cardiovascular.
Abstract
Background: COVID-19 challenged our health system, within the broad clinical spectrum acute kidney injury was presented as a catastrophic event, acute kidney injury and the risk of dependency after dialysis constitute a clinical problem with high repercussions in the funcionality.
Objective: To identify risk factors for dialysis dependence after acute kidney injury from COVID-19.
Material and methods: A retrospective observational cohort study was carried out at the Hospital de Especialidades del Centro Médico Nacional Siglo XXI, of the Mexican Institute of Social Security, from March 2020 to March 2021. 317 patients were included, we performed descriptive statistics, we compared differences between the stages of acute kidney injury, finding a difference in obesity with a frequency of 2.2% in stage 1, 20.82% stage 2 and 14.51% stage 3, with p value = 0.018.
Results: We found dialysis dependence one year after hospital-acquired acute kidney injury induced by COVID-19 in 58 patients (18.9%), we analyzed by KDIGO stage, in those patients who had AKI KDIGO 1 (2.83%) it depended on dialysis at one year, in the KDIGO stage 2 (3.78%), in the KDIGO stage 3 (11.67%)
Conclusions: Our study allowed us to identify that the risk factors associated with dialysis dependence are: male gender, type 2 diabetes mellitus, obesity, cardiovascular disease.
Attaway AH, Scheraga RG, Bhimraj A, Biehl M, Hatipoğlu U. Severe covid-19 pneumonia: pathogenesis and clinical management. BMJ [Internet]. 2021 [citado el 20 de enero de 2023];372:n436. Disponible en: https://www.bmj.com/content/372/bmj.n436.
Pei G, Zhang Z, Peng J, Liu L, Zhang C, Yu C, et al. Renal involvement and early prognosis in patients with COVID-19 pneumonia. J Am Soc Nephrol [Internet]. 2020 [citado el 20 de enero de 2023]; 31(6):1157-65. Disponible en: https://pubmed. ncbi.nlm.nih.gov/32345702/
Yang X, Jin Y, Li R, Zhang Z, Sun R, Chen D. Prevalence and impact of acute renal impairment on COVID-19: a systematic review and meta-analysis. Crit Care [Internet]. 2020 [citado el 20 de enero de 2023];24(1):356. Disponible en: https:// pubmed.ncbi.nlm.nih.gov/32552872/
Lin L, Wang X, Ren J, Sun Y, Yu R, Li K, et al. Risk factors and prognosis for COVID-19-induced acute kidney injury: a meta-analysis. BMJ Open [Internet]. 2020;10(11):e042573. Disponible en: http://dx.doi.org/10.1136/bmjopen-2020-042573.
Alfano G, Ferrari A, Fontana F, Mori G, Magistroni R, Meschiari M, et al. Incidence, risk factors and outcome of acute kidney injury (AKI) in patients with COVID-19. Clin Exp Nephrol [Internet]. 2021;25(11):1203-14. Disponible en: http://dx.doi. org/10.1007/s10157-021-02092-x.
Mogga P, Venkatraman S, Rajagopalan U, Rajagopalan P, Radhan P, Maithrayie K, et al. Correlation of AKI with risk factors, ventilatory support, renal replacement therapy in a cohort of COVID-19 patients. Indian J Nephrol [Internet]. 2022; 32(4):348-58. Disponible en: http://dx.doi.org/10.4103/ijn. ijn_350_21.
Sullivan MK, Lees JS, Drake TM, Docherty AB, Oates G, Hardwick HE, et al. Acute kidney injury in patients hospitalized with COVID-19 from the ISARIC WHO CCP-UK Study: a prospective, multicentre cohort study. Nephrol Dial Transplant [Internet]. 2022 [citado el 20 de enero de 2023];37 (2):271-84. Disponible en: https://academic.oup.com/ndt/article/37/2/271/6400122.
Fisher M, Neugarten J, Bellin E, Yunes M, Stahl L, Johns TS, et al. AKI in hospitalized patients with and without COVID-19: A comparison study. J Am Soc Nephrol [Internet]. 2020;31(9):2145-57. Disponible en: http://dx.doi.org/10.1681/ ASN.2020040509.
Smilowitz NR, Kunichoff D, Garshick M, Shah B, Pillinger M, Hochman JS, et al. C-reactive protein and clinical outcomes in patients with COVID-19. Eur Hear J [Internet]. 2021; 42(23):2270-9. Disponible en: http://dx.doi.org/10.1093/ eurheartj/ehaa1103.
Nadim MK, Forni LG, Mehta RL, Connor MJ Jr, Liu KD, Ostermann M, et al. COVID-19-associated acute kidney injury: consensus report of the 25th Acute Disease Quality Initiative (ADQI) Workgroup. Nat Rev Nephrol [Internet]. 2020; 16(12):747-64. Disponible en: http://dx.doi.org/10.1038/ s41581-020-00356-5.
Chávez-Íñiguez JS, Cano-Cervantes JH, Maggiani-Aguilera P, Lavelle-Góngora N, Marcial-Meza J, Camacho-Murillo EP, et al. Mortality and evolution between community and hospital-acquired COVID-AKI. PLoS One [Internet]. 2021;16(11): e0257619. Disponible en: http://dx.doi.org/10.1371/journal. pone.0257619.
Martínez-Rueda AJ, Álvarez RD, Méndez-Pérez RA, Fernández-Camargo DA, Gaytan-Arocha JE, Berman-Parks N, et al. Community- and hospital-acquired acute kidney injury in COVID-19: Different phenotypes and dismal prognosis. Blood Purif [Internet]. 2021;50(6):931-41. Disponible en: http://dx.doi. org/10.1159/000513948.
Hernández-Rivera J-C-H, Silva-Rueda R-I, Salazar-Mendoza M, Pazos-Pérez F, Pérez-López M-J, Bermúdez-Aceves L, et al. COVID-19 generalidades y enfermedad renal. Artículo de revisión. Gac médica Bilbao [Internet]. 2021 [citado el 20 de enero de 2023];118(2):143-59. Disponible en: http://www. gacetamedicabilbao.eus/index.php/gacetamedicabilbao/ article/view/849.
Hsu CM, Gupta S, Tighiouart H, Goyal N, Faugno AJ, Tariq A, et al. Kidney recovery and death in critically ill patients with COVID-19-associated acute kidney injury treated with dialysis: The STOP-COVID cohort study. Am J Kidney Dis [Internet]. 2022;79(3):404-416.e1. Disponible en: http://dx.doi. org/10.1053/j.ajkd.2021.11.004.
Guía clínica para el tratamiento de la COVID-19 en México. Ciudad de México, México: Secretaría de Salud; 2021. Disponible en: https://coronavirus.gob.mx/wpcontent/uploads/2021/08/ GuiaTx_COVID19_ConsensoInterinstitucional_2021.08.03.pdf.
Summary of recommendation statements section 1: Introduction and methodology. (n.d.). Kdigo.org. Retrieved December 28, 2022, from https://kdigo.org/wp-content/uploads/2016/10/ KDIGO-2012-AKI-Guideline-English.pdf.
Vijayan A, Abdel-Rahman EM, Liu KD, Goldstein SL, Agarwal A, Okusa MD, et al. Recovery after critical illness and acute kidney injury. Clin J Am Soc Nephrol [Internet]. 2021;16(10):1601- 9. Disponible en: http://dx.doi.org/10.2215/CJN.19601220.
Institute for Health Metrics and Evaluation (IHME). Global Burden Disease Compare Data Visualization. Seattle, WA: IHME (2019).
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet [Internet]. 2020;395(10223):497-506. Disponible en: http://dx.doi.org/10.1016/S0140-6736(20)30183-5.
Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract [Internet]. 2010;87(1):4-14. Disponible en: http://dx.doi. org/10.1016/j.diabres.2009.10.007.
Ma C-X, Ma X-N, Guan C-H, Li Y-D, Mauricio D, Fu S-B. Cardiovascular disease in type 2 diabetes mellitus: progress toward personalized management. Cardiovasc Diabetol [Internet]. 2022;21(1):74. Disponible en: http://dx.doi.org/10.1186/ s12933-022-01516-6.
Kumar A, Arora A, Sharma P, Anikhindi SA, Bansal N, Singla V, et al. Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis. Diabetes Metab Syndr [Internet]. 2020;14(4):535-45. Disponible en: http://dx.doi.org/ 10.1016/j.dsx.2020.04.044.
Flythe JE, Assimon MM, Tugman MJ, Chang EH, Gupta S, Shah J, et al. Characteristics and outcomes of individuals with pre-existing kidney disease and COVID-19 admitted to intensive care units in the United States. Am J Kidney Dis [Internet]. 2021;77(2):190-203.e1. Disponible en: http://dx.doi. org/10.1053/j.ajkd.2020.09.003.
Lumlertgul N, Pirondini L, Cooney E, Kok W, Gregson J, Camporota L, et al. Acute kidney injury prevalence, progression and long-term outcomes in critically ill patients with COVID-19: a cohort study. Ann Intensive Care [Internet]. 2021;11(1):123. Disponible en: http://dx.doi.org/10.1186/ s13613-021-00914-5.
Roushani J, Thomas D, Oliver MJ, Ip J, Tang Y, Yeung A, et al. Acute kidney injury requiring renal replacement therapy in people with COVID-19 disease in Ontario, Canada: a prospective analysis of risk factors and outcomes. Clin Kidney J [Internet]. 2022;15(3):507-16. Disponible en: http://dx.doi. org/10.1093/ckj/sfab237.
Karadag S, Ozturk S, Arici . Post-COVID-19 outcomes of non-dialysis dependent chronic kidney disease patients: a national, multicenter, controlled study [published online ahead of print, 2022 Aug 11]. Int Urol Nephrol. 2022;1-10 Nih.gov. [citado el 20 de enero de 2023]. Disponible en: https://www.ncbi.nlm.nih. gov/pmc/articles/PMC9366804/
Moledina DG, Simonov M, Yamamoto Y, Alausa J, Arora T, Biswas A, et al. The association of COVID-19 with acute kidney injury independent of severity of illness: A multicenter cohort study. Am J Kidney Dis [Internet]. 2021;77(4):490-499.e1. Disponible en: http://dx.doi.org/10.1053/j.ajkd.2020.12.007.
Zhang P, Zhu L, Cai J, Lei F, Qin J-J, Xie J, et al. Association of inpatient use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19. Circ Res [Internet]. 2020 [citado el 23 de enero de 2023];126 (12):1671-81. Disponible en: https://pubmed.ncbi.nlm.nih. gov/32302265/
Flannery AH, Kiser AS, Behal ML, Li X, Neyra JA. RAS inhibition and sepsis-associated acute kidney injury. J Crit Care [Internet]. 2022 [citado el 23 de enero de 2023];69 (153986):153986. Disponible en: https://pubmed.ncbi.nlm. nih.gov/35085853/
Xu C, Chen Y, Yu J. Foe and friend in the COVID-19-associated acute kidney injury: an insight on intrarenal renin-angiotensin system. Acta Biochim Biophys Sin (Shanghai) [Internet]. 2022 [citado el 23 de enero de 2023];54(1):1-11. Disponible en: https://pubmed.ncbi.nlm.nih.gov/35130610/